Authors
Loading...
This study shows IRF5 is essential for hemophagocytosis and disease in mice with Macrophage Activation Syndrome, implying it may be a therapeutic target.
Thulin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: